Slide 1
LabDisk-Analyzer

We take dermatological diagnostics to the next level. The Dermagnostix system evaluates skin at gene ex-pression level to deliver objective and precise information of patients’ individual molecular signature to guide clinical decision-making.

Slide 1
LabDisk-Analyzer

We take dermatological diagnostics to the next level. The Dermagnostix system evaluates skin at gene ex-pression level to deliver objective and precise information of patients’ individual molecular signature to guide clinical decision-making.

Slide 1
LabDisk-Analyzer

We take dermatological diagnostics to the next level. The Dermagnostix system evaluates skin at gene ex-pression level to deliver objective and precise information of patients’ individual molecular signature to guide clinical decision-making.

previous arrowprevious arrow
next arrownext arrow

Your Solution for more Efficiency and Accuracy 

The Fully Automated LabDisk-Analyzer

Dermatology faces unique challenges in accurately diagnosing similar-looking conditions like psoriasis and eczema. Up to 50% of cases face diagnostic uncertainty1,2 , making treatment decisions challenging and leading to potential delays in patient care.

The LabDisk-Analyzer by Dermagnostix addresses these pain points directly by introducing an objective, microfluidics-based approach to dermatology diagnostics.

Its plug-and-play setup minimizes the need for extensive staff training and reduces dependency on disposable lab materials, leading to cost savings. By combining innovation with reliability, the LabDisk-Analyzer is setting new standards in dermatology, ensuring patients receive the targeted care they need, while laboratories gain a competitive advantage in accuracy and efficiency.

The fully automated Dermagnostix system includes the LabDisk, which integrates advanced molecular testing into a compact, easy-to-use format that supports diagnostic accuracy.

The test results are stored in the Dermagnostix cloud-based software, where you benefit from fast customer support and over-the-air software updates. These features enable quick generation of diagnostic reports through simple copy and paste. With the system's high precision, dermatologists and dermatopathologists gain a reproducible and standardized method for differential diagnosis of complex skin diseases, enhancing their confidence in results.

References

  • Coimbra S, Santos-Silva A. (2015): A specific molecular signature for psoriasis and eczema. Ann Transl Med 3:76.
  • Kolesnik M et al. (2018): Eczema in Psoriatico: An Important Differential Diagnosis Between Chronic Allergic Contact Dermatitis and Psoriasis in Palmoplantar Localization. Acta dermato-venereologica 98:50-8.
  • Setting New Standards in Dermatological Diagnostics

    Your Benefits at a Glance

    • Simple and user-friendly: Insert sample into the LabDisk, insert LabDisk into the Analyzer and start the analysis – fully automated and usable by minimally trained staff.
    • Fast: Results in 1-2 hours for timely therapy decisions and rapid diagnostic report generation using the Dermagnostix Cloud.
    • Point-of-Care: Objective diagnostics accessible anytime, anywhere.
    • Plug and play: Validation- and maintenance-free device, easily integrated into your lab with minimal effort. 
    • Made in Germany: Fully developed and produced in Germany in compliance with IVDR regulations.

    More Dermagnostix Products

    PsorX-LabDisk

    The PsorX-LabDisk, in combination with the LabDisk-Analyzer, delivers unparalleled accuracy and speed for dermatology diagnostics. This molecular test for differentiating psoriasis and eczema empowers dermatopathologists with precise gene expression-based insights in just two hours. Together with the LabDisk-Analyzer, it creates a fully automated, user-friendly diagnostic platform designed to minimize uncertainty and support clinical workflows.

    Pipeline Products

    Explore our innovative upcoming products transforming molecular diagnostics for dermatology: PsorX 2.0 for the differential diagnosis of psoriasis, eczema and tinea using non-invasive sampling for the use at the point-of-care. LymphX for the differential diagnosis of mycosis fungoides, psoriasis, and eczema, enabling earlier and more accurate diagnosis. And PatternX to support clinicans with biomarker characterization and stratification of patients according to moelcular patterns.

    YouTube

    By loading the video, you agree to YouTube's privacy policy.
    Learn more

    Load video

    Shaping the Future of Dermatology Together!

    Discover how our user-friendly solutions can modernize your pathology lab.
    Get all your questions answered and enhance diagnostic precision with our products.

    Explore how our objective molecular solutions increase your diagnostic precision to make the best treatment decisions for your patients. Explore our Point-of-Care product pipeline.

    Unlock the potential of our innovative diagnostics and see how your investment can drive advancements in medicine. Discover opportunities for growth and impact.

    Want to know more?

    Dr. Susann Lindemeyer 
    Sales Representative
    info@dermagnostix.com